Advertisement · 728 × 90
#
Hashtag
#Antiplatelet
Advertisement · 728 × 90
Post image

New findings reveal that while BPA analogues show minimal effects on coagulation or erythrocytes at achievable concentrations, bisphenol PH is a potent antiplatelet agent acting through COX‑1 inhibition, potentially elevating bleeding risk. doi.org/10.1016/j.et...
#bisphenols #antiplatelet

0 0 0 0
Anticoagulation vs Antiplatelets Across Subgroups of Embolic Stroke of Undetermined Source | Neurology Background and ObjectivesThe term “embolic stroke of undetermined source” (ESUS) encompasses a substantial but heterogeneous population of patients with ischemic stroke, underscoring the importance of identifying personalized treatment strategies. In ...

8/ #ESUS = suspected cardioembolic stroke but w/o afib. #Anticoagulation in this patient population has not definitively demonstrated to be superior to #antiplatelet



A recent meta analysis of the available trials showed no superiority:

0 0 1 0
Video

HIGHLIGHTS FROM AUGUST ISSUE

🗣️Expert Guidance for Severe #Bleeding on #OralAnticoagulation

💊 #Antiplatelet for High Ischaemic and Bleeding Risks Patients After #PCI

Validity of #DIC Based on ICD-10 in a Claims Database

read more: tinyurl.com/2ssjnsv2

1 0 0 0
Post image

#antiplatelet #health #gerontology #primaryhealthcare #pathology #bloodclot

Platelet hyperreactivity and aggregation

are promoted by
gut-liver metabolites, such as
indoxyl sulfate, PAGln, and TMAO,

and reduced by sunlight (near-infrared, vitamin D),
and nighttime endogenous melatonin synthesis.

0 0 0 0
Post image

🚨 Retrospective study: Platelet transfusions don’t prevent ventriculostomy hemorrhage in aSAH—even on DAPT

🔄 Timing didn’t matter
❌ No outcome benefit
🧠 Symptomatic bleeds still rare

📖 doi.org/10.1016/j.jo...

#NeurocriticalCare #Neurosurgery #SAH #Antiplatelet #ICU #NeuroTwitter #MedTwitter

2 0 0 0
Post image

Summary of the guideline recs for #anticoagulant & #antiplatelet therapy in ACS c/w prior recs in @americanheart.bsky.social @accintouch.bsky.social and @escardio.bsky.social guidelines. Thankful to Writing Committee & also a great team who made this summary possible:
www.jacc.org/doi/10.1016/...

7 6 1 0
Post image Post image

Longtime #HMS collaborative partner Dr. Scott Kaatz made the morning fun with a session on perioperative #anticoagulation & #antiplatelet management.

🩸From warfarin tips to DOAC strategies, plus live interaction & prizes – it was a jackpot! 🎰
#SHMConverge25

1 0 0 0
Video

Genotype-guided #antiplatelet therapy can optimize the balance between ischemic & bleed risk for #ACS patients. The CE marked Genomadix Cube can help! Benefits include:
✅1 hour results
✅No liquid handling
✅No incubations

1. van den Broek et al. JACC.2024;84:1107-1118.

#Cardiology #DAPT

0 0 0 0
Preview
Pharmacodynamic interaction between ginger and antiplatelet drugs: A case report Pharmacodynamic interaction between ginger and antiplatelet drugs: A case report

Letter to editor

Pharmacodynamic interaction between ginger and antiplatelet drugs: A case report

www.em-consulte.com/article/1726...

#Herb #drug #Interaction #Antiplatelet #Agent #Clopidogrel #Ginger #AdverseEffects

0 0 0 0
Preview
Aplagon secures EUR 7 million for APAC phase 2a trials - PharmaTimes Funding led by new investors FSG and EIC Fund

#Aplagon #APACtherapeutic #thromboinflammatorydiseases #heparinproteoglycanmimetic #antiplatelet #anticoagulant #mastcellderivedheparinproteoglycans #antithrombotic #antiinflammatory #peripheralarterialocclusivedisease #chroniclimbthreateningischemia #PAOD #CLTI
pharmatimes.com/news/aplagon...

0 0 0 0
Post image

When pts have stable #CAD & #AF, do we need both #anticoagulant therapy and #antiplatelet agents? Our collaborative meta-analysis of RCTs shows that monotherapy with anticoagulation ⬇️🩸 without a large increase in ischemic events. @jaccjournals.bsky.social

www.jacc.org/doi/10.1016/...

6 3 1 0

www.cell.com/trends/pharm...

www.cell.com/trends/pharm...

#CVD #platelet #demographic #population #antiplatelet

3 0 0 0
Post image

23) The authors concluded that #abelacimab tended to provide a greater absolute risk reduction for 🩸 in pts on #antiplatelet therapy than a conventional #DOAC, even beyond the difference seen in #AZALEA for pts treated overall. The #FXI hypothesis continues to be strengthened!

0 0 1 0
Post image

The latest @BMJ_Qual_Saf blog on clinical improving #antiplatelet therapy uptake:

blogs.bmj.com/qualitysafety/…

#cardiovascularhealth #healthinequity #medication #QI

2 0 0 0